ArticleActa pharmacologica Sinica2022

SAF-248, a novel PI3Kδ-selective inhibitor, potently suppresses the growth of diffuse large B-cell lymphoma.

Xi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.